Your browser doesn't support javascript.
loading
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors.
Teixeira, Luis; Medioni, Jacques; Garibal, Julie; Adotevi, Olivier; Doucet, Ludovic; Durey, Marie-Agnès Dragon; Ghrieb, Zineb; Kiladjian, Jean-Jacques; Brizard, Mara; Laheurte, Caroline; Wehbe, Maria; Pliquet, Elodie; Escande, Marie; Defrance, Rémy; Culine, Stephane; Oudard, Stephane; Wain-Hobson, Simon; Doppler, Valérie; Huet, Thierry; Langlade-Demoyen, Pierre.
Afiliação
  • Teixeira L; Breast Diseases Unit, HIPI INSERM U976, AP-HP, Saint Louis Hospital, Paris University, Paris, France.
  • Medioni J; Center for Early Clinical Trials, Medical Oncology Department (CEPEC), Georges Pompidou Hospital, Paris Descartes University, Paris, France.
  • Garibal J; Invectys, Paris BioPark, Paris, France. julie.garibal@invectys.com.
  • Adotevi O; University of Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Biomonitoring Platform, Besançon, France.
  • Doucet L; Breast Diseases Unit, HIPI INSERM U976, AP-HP, Saint Louis Hospital, Paris University, Paris, France.
  • Durey MD; Immunobiology Laboratory, Georges Pompidou Hospital, Paris, France.
  • Ghrieb Z; Breast Diseases Unit, HIPI INSERM U976, AP-HP, Saint Louis Hospital, Paris University, Paris, France.
  • Kiladjian JJ; Breast Diseases Unit, HIPI INSERM U976, AP-HP, Saint Louis Hospital, Paris University, Paris, France.
  • Brizard M; Center for Early Clinical Trials, Medical Oncology Department (CEPEC), Georges Pompidou Hospital, Paris Descartes University, Paris, France.
  • Laheurte C; University of Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Biomonitoring Platform, Besançon, France.
  • Wehbe M; Invectys, Paris BioPark, Paris, France.
  • Pliquet E; Invectys, Paris BioPark, Paris, France.
  • Escande M; Invectys, Paris BioPark, Paris, France.
  • Defrance R; Invectys, Paris BioPark, Paris, France.
  • Culine S; Breast Diseases Unit, HIPI INSERM U976, AP-HP, Saint Louis Hospital, Paris University, Paris, France.
  • Oudard S; Center for Early Clinical Trials, Medical Oncology Department (CEPEC), Georges Pompidou Hospital, Paris Descartes University, Paris, France.
  • Wain-Hobson S; Invectys, Paris BioPark, Paris, France.
  • Doppler V; Invectys, Paris BioPark, Paris, France.
  • Huet T; Invectys, Paris BioPark, Paris, France.
  • Langlade-Demoyen P; Invectys, Paris BioPark, Paris, France.
Clin Cancer Res ; 26(3): 588-597, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31558479
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article